Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01897
Species: Homo sapiens
Position : chr8:127675276-128081453
Year: 2024
Title: Epigenetic remodeling and 3D chromatin reorganization governed by NKX2-1 drive neuroendocrine prostate cancer
Genome Build: hg38
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  39677680
MONDO: MONDO:0008315
Tissue: Prostate
Tissue Ontology ID: UBERON:0002367
Cell Source: LuNE
CVCL ID:
Cell Type: prostate carcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Western blot, qRT-PCR
About Target Gene
Target gene : MYC
About TF
TF name : FOXA2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA2 FOXA1 transcription factor network pid 45
FOXA2 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA2 Hedgehog signaling events mediated by Gli proteins pid 49
FOXA2 Regulation of gene expression in beta cells reactome 17
FOXA2 Maturity onset diabetes of the young kegg 25
FOXA2 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
FOXA2 Hs_Dopaminergic_Neurogenesis_WP2855_87239 wikipathways 19
FOXA2 Hs_Heart_Development_WP1591_90186 wikipathways 28
FOXA2 Hs_Ectoderm_Differentiation_WP2858_89329 wikipathways 56
Enhancer Associated Network
Overlapping Enhancers (hg38) 4 found
Enhancer ID Position Tissue Cell Disease
E_01708 chr8:126650000-129950000 Colon colorectal carcinoma cell colorectal carcinoma
E_01465 chr8:127750000-127752000 Breast breast carcinoma cell breast carcinoma
E_01650 chr8:127750000-127752000 Breast breast carcinoma cell breast carcinoma
E_01694 chr8:128041672-128043891 Bone Marrow hematopoietic stem cell --
Expression of Target Genes for the Enhancer